Pivotal bioVenture Partners Fund I L.P. 13D and 13G filings for Iterum Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-09 5:02 pm Sale | 2020-12-31 | 13G | Iterum Therapeutics plc ITRM | Pivotal bioVenture Partners Fund I L.P. | 63,006 1.200% | -0 (-0.00%) | Filing |